Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Tongue Neoplasms 1Thyroid Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Pain 1Mucositis 1Mesothelioma 1Lymphoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 29Magnetic Resonance Spectroscopy 16Specimen Handling 13Radiotherapy 12pembrolizumab 11Radiotherapy, Intensity-Modulated 11Cetuximab 11Surgical Procedures, Operative 9Paclitaxel 9Fluorouracil 9Docetaxel 9Platinum 81,2-diaminocyclohexaneplatinum II citrate 8Radiation 6Carboplatin 6Taxes 5Biopsy 5toripalimab 4X-Rays 4Surveys and Questionnaires 4Fluorodeoxyglucose F18 4Chemoradiotherapy 4Celecoxib 4(225)Ac-DOTA-c(RGDyK) 4Immunohistochemistry 3Counseling 3130-nm albumin-bound paclitaxel 3motexafin gadolinium 2ipatasertib 2camrelizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypopharyngeal Neoplasms × Doxepin × Clear all
NCT02062632 2019-10-01

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Mayo Clinic

Phase 2 Terminated
5 enrolled 4 charts
GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphoma, Mesothelioma, Sarcoma, Thymoma, Thyroid Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡